VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $281,194 | -93.5% | 30,010 | -83.1% | 0.00% | -88.9% |
| Q2 2023 | $4,359,005 | +5.4% | 177,701 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $4,135,103 | +43.1% | 177,701 | +55.6% | 0.01% | +28.6% |
| Q4 2022 | $2,890,149 | +40.3% | 114,190 | +6.9% | 0.01% | +40.0% |
| Q3 2022 | $2,060,000 | +17.8% | 106,840 | +55.5% | 0.01% | +25.0% |
| Q2 2022 | $1,749,000 | -40.1% | 68,689 | -39.5% | 0.00% | -33.3% |
| Q1 2022 | $2,919,000 | -36.9% | 113,509 | +2.7% | 0.01% | -33.3% |
| Q4 2021 | $4,629,000 | +458.4% | 110,569 | +358.3% | 0.01% | +350.0% |
| Q3 2020 | $829,000 | +265.2% | 24,128 | +334.7% | 0.00% | +100.0% |
| Q2 2020 | $227,000 | – | 5,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |